Diclofenac Potentiates Sorafenib-Based Treatments of Hepatocellular Carcinoma by Enhancing Oxidative Stress
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diclofenac Potentiates Sorafenib-Based Treatments of Hepatocellular Carcinoma by Enhancing Oxidative Stress
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 10, Pages 1453
Publisher
MDPI AG
Online
2019-09-27
DOI
10.3390/cancers11101453
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chemosensitization of hepatocellular carcinoma cells to sorafenib by β-caryophyllene oxide-induced inhibition of ABC export pumps
- (2019) Silvia Di Giacomo et al. ARCHIVES OF TOXICOLOGY
- Oncofetal HLF transactivates c-Jun to promote hepatocellular carcinoma development and sorafenib resistance
- (2019) Dai-Min Xiang et al. GUT
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Molecular therapies and precision medicine for hepatocellular carcinoma
- (2018) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Aspirin plus sorafenib potentiates cisplatin cytotoxicity in resistant head and neck cancer cells through xCT inhibition
- (2017) Jong-Lyel Roh et al. FREE RADICAL BIOLOGY AND MEDICINE
- ROS in Cancer: The Burning Question
- (2017) Iok In Christine Chio et al. TRENDS IN MOLECULAR MEDICINE
- Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines
- (2017) Yuki Haga et al. PLoS One
- International incidence and mortality trends of liver cancer: a global profile
- (2017) Martin C. S. Wong et al. Scientific Reports
- Identification of a novel oxidative stress induced cell death by Sorafenib and oleanolic acid in human hepatocellular carcinoma cells
- (2016) Matthias Lange et al. BIOCHEMICAL PHARMACOLOGY
- Activation of apoptosis signalling pathways by reactive oxygen species
- (2016) Maureen Redza-Dutordoir et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Diclofenac induces proteasome and mitochondrial dysfunction in murine cardiomyocytes and hearts
- (2016) Rajeshwary Ghosh et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Reactive oxygen species induced by non-steroidal anti-inflammatory drugs enhance the effects of photodynamic therapy in gastric cancer cells
- (2016) Hiromu Ito et al. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
- Activation of c-Jun predicts a poor response to sorafenib in hepatocellular carcinoma: Preliminary Clinical Evidence
- (2016) Wei Chen et al. Scientific Reports
- Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells
- (2015) Xiaofang Sun et al. HEPATOLOGY
- Differential Combined Effect of COX Inhibitors on Cell Survival Suppressed by Sorafenib in the HepG2 Cell Line
- (2014) Kenta Yagi et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- ROS Function in Redox Signaling and Oxidative Stress
- (2014) Michael Schieber et al. CURRENT BIOLOGY
- Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis
- (2014) Scott J Dixon et al. eLife
- Synergistic antitumour activity of sorafenib in combination with tetrandrine is mediated by reactive oxygen species (ROS)/Akt signaling
- (2013) J Wan et al. BRITISH JOURNAL OF CANCER
- NSAIDs Inhibit Tumorigenesis, but How?
- (2013) Evrim Gurpinar et al. CLINICAL CANCER RESEARCH
- Tyrosine kinase inhibitors and drug interactions: a review with practical recommendations
- (2012) Bella Pajares et al. Clinical & Translational Oncology
- Synthetic Lethal Screening with Small-Molecule Inhibitors Provides a Pathway to Rational Combination Therapies for Melanoma
- (2012) D. G. Roller et al. MOLECULAR CANCER THERAPEUTICS
- Sorafenib-Induced Hepatocellular Carcinoma Cell Death Depends on Reactive Oxygen Species Production In Vitro and In Vivo
- (2012) R. Coriat et al. MOLECULAR CANCER THERAPEUTICS
- Role of antioxidants in cancer therapy
- (2012) Vanessa Fuchs-Tarlovsky NUTRITION
- The non-steroidal anti-inflammatory drugs Sulindac sulfide and Diclofenac induce apoptosis and differentiation in human acute myeloid leukemia cells through an AP-1 dependent pathway
- (2011) Raminder Singh et al. APOPTOSIS
- Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance?
- (2011) Anna Brózik et al. Expert Opinion on Drug Metabolism & Toxicology
- Signal transduction by reactive oxygen species
- (2011) Toren Finkel JOURNAL OF CELL BIOLOGY
- Cytochrome P450 2C9-CYP2C9
- (2010) Derek Van Booven et al. Pharmacogenetics and Genomics
- Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage?
- (2010) Fernando Bessone WORLD JOURNAL OF GASTROENTEROLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started